Interstitial Fluid Pressure as a Prognostic Factor in Cervical Cancer Following Radiation Therapy

• Published in: Clinical cancer research 2009-10, Vol.15 (19), p.6201-6207
• Main Authors: YEO, Seung-Gu, KIM, Jun-Sang, CHO, Moon-June, KIM, Ki-Hwan, KIM, Jae-Sung
• Format: Article
• Language: English
• Subjects: Adenocarcinoma - diagnosis; Adenocarcinoma - mortality; Adenocarcinoma - radiotherapy; Adult; Aged; Antineoplastic agents; Biological and medical sciences; Carcinoma, Squamous Cell - diagnosis; Carcinoma, Squamous Cell - mortality; Carcinoma, Squamous Cell - radiotherapy; Cervical cancer; Dose Fractionation; Extracellular Fluid - physiology; Extracellular Fluid - radiation effects; Female; Female genital diseases; Follow-Up Studies; Gynecology. Andrology. Obstetrics; Humans; Interstitial fluid pressure; Medical sciences; Middle Aged; Pharmacology. Drug treatments; Pressure; Prognosis; Prognostic factor; Radiation therapy; Radiotherapy Dosage; Survival; Survival Analysis; Treatment Outcome; Tumors; Uterine Cervical Neoplasms - diagnosis; Uterine Cervical Neoplasms - mortality; Uterine Cervical Neoplasms - radiotherapy
• ISSN: 1078-0432; 1557-3265
• DOI: 10.1158/1078-0432.CCR-09-0560

Purpose: To investigate tumor interstitial fluid pressure as a prognostic factor for recurrence-free survival in patients with cervical cancer following radiation therapy. Experimental Design: Tumor interstitial fluid pressure was measured in 55 cervical cancer patients who received radiation therapy between August 1998 and September 2002. Interstitial fluid pressure measurements were made before radiation therapy (pre–radiation therapy interstitial fluid pressure) and after a median of 28.8 Gy in 16 fractions (range, 25.2-30.6 Gy in 14-17 fractions) of radiation therapy (mid–radiation therapy interstitial fluid pressure), using a modified wick-in-needle technique. Median follow-up was 74 months (range, 2-118 months). The Kaplan-Meier method with the log-rank test and Cox's proportional hazard model were used in univariate and multivariate analyses, respectively, of prognostic factors for recurrence-free survival. Results: Median pre–radiation therapy and mid–radiation therapy interstitial fluid pressure were 29.0 mm Hg (range, 4.0-93.9 mm Hg) and 20.0 mm Hg (range, −1.2 to 29.6 mm Hg), respectively ( P = 0.001). Pre–radiation therapy interstitial fluid pressure was significantly higher in adenocarcinomas than squamous cell carcinomas ( P = 0.028). Significant reduction of interstitial fluid pressure was noted only in patients with complete responses ( P = 0.002), and mid–radiation therapy interstitial fluid pressure was significantly lower in patients with complete responses ( P = 0.036). In the multivariate analysis including interstitial fluid pressures and clinical variables, pre–radiation therapy interstitial fluid pressure was an independent prognostic factor for local and distant recurrence-free survival ( P = 0.001 and 0.027, respectively). Conclusions: Mid–radiation therapy interstitial fluid pressure measurement may be useful in predicting radiation therapy responses, and pre–radiation therapy interstitial fluid pressure was a significant prognostic factor for local and distant relapse-free survival in patients with cervical cancer after radiation therapy. (Clin Cancer Res 2009;15(19):6201–7)